Emerging Stocks Down Under 23 March 2021: Race Oncology, Family Zone Cyber Safety, Strategic Elements

Race Oncology: Racing up, but may get puffed soon

In today’s edition of Emerging Stocks Down Under, in June 2020 you could get the cancer drug developer Race Oncology for just over 30 cents a share. Suddenly it went over $1.00 and even though it was back at 75 cents on 8 October, the best was yet to come. By 11 March 2021 Race Oncology had raced all the way to $4.07. Investors clearly reckon Race Oncology has an approvable drug. They might, we fear, get tired of waiting though.

 

Also in today’s edition, a look at student and family cyber security developer Family Zone Cyber Safety (ASX: FZO) and technology incubator Strategic Elements (ASX: SOR).

 

 

 

Click here to read the previous edition of Emerging Stocks Down Under published 16 March 2021

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.